GINKGO BIOWORKS HOLDINGS, INC. Restructuring Costs and Asset Impairment Charges
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Restructuring Costs and Asset Impairment Charges of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2026-08-06
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for the quarter ending 2025-12-31 was $706.00K, a 83.02% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for the quarter ending 2025-09-30 was $1.75M, a 40.83% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for fiscal 2025 was $11.40M, a 52.85% decline from fiscal 2024.
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for fiscal 2024 was $24.17M.
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for fiscal 2023 was $0.00.
- GINKGO BIOWORKS HOLDINGS, INC. restructuring costs and asset impairment charges for fiscal 2022 was $0.00.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 3 month as first filed | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 6 month as first filed | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 9 month as first filed | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $706.00K derived: sum of 3 quarters · filed 2026-08-06 | $2.45M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $706.00K derived: sum of 2 quarters · filed 2026-05-07 | $2.45M derived: sum of 3 quarters · filed 2026-05-07 | $6.02M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.45M derived: sum of 2 quarters · filed 2026-02-26 | $6.02M derived: sum of 3 quarters · filed 2026-08-06 | $11.40M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $1.75M 10-Q · filed 2025-11-06 | $5.31M derived: sum of 2 quarters · filed 2026-08-06 | $10.69M 10-Q · filed 2025-11-06 | $13.93M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $3.57M 10-Q · filed 2026-08-06 | $3.67M 10-Q · filed 2025-08-07 | $8.03M 10-Q · filed 2026-08-06 | $8.95M 10-Q · filed 2025-08-07 | $12.19M derived: sum of 3 quarters · filed 2026-08-06 | $15.14M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $4.47M 10-Q · filed 2026-05-07 | $5.27M 10-Q · filed 2025-05-06 | $8.62M derived: sum of 2 quarters · filed 2026-05-07 | $11.57M derived: sum of 3 quarters · filed 2026-05-07 | $28.64M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.11M derived: sum of 2 quarters · filed 2026-02-26 | $24.17M derived: sum of 3 quarters · filed 2026-02-26 | $24.17M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $2.95M 10-Q · filed 2025-11-06 | $20.02M derived: sum of 2 quarters · filed 2025-11-06 | $20.02M 10-Q · filed 2025-11-06 | $15.19M 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $17.07M 10-Q · filed 2025-08-07 | $17.07M 10-Q · filed 2025-08-07 | $4.82M 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | ||||||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | ||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | ||||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-25 |